Chawla-Sarkar, M <br/><br/>
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.  [electronic resource] 

 -  Cell death and differentiation  Aug 2004 
 - 915-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1350-9047 
<br/><br/><label>Standard No.: </label>10.1038/sj.cdd.4401416  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins<br/>BH3 Interacting Domain Death Agonist Protein<br/>CASP8 and FADD-Like Apoptosis Regulating Protein<br/>Carrier Proteins--metabolism<br/>Caspase 9<br/>Caspases--metabolism<br/>Genes, bcl-2--physiology<br/>Humans<br/>Inhibitor of Apoptosis Proteins<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Melanoma--metabolism<br/>Membrane Glycoproteins--metabolism<br/>Microtubule-Associated Proteins--metabolism<br/>Neoplasm Proteins<br/>Proteins--metabolism<br/>RNA, Small Interfering--genetics<br/>Survivin<br/>TNF-Related Apoptosis-Inducing Ligand<br/>Tumor Cells, Cultured<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>X-Linked Inhibitor of Apoptosis Protein